カテゴリ： 世界, 医療/バイオ, QYResearch

テノキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%

■ 英語タイトル：Global Tenoxicam API Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8904）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8904
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[テノキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はテノキシカムAPIのグローバル市場について調査・分析し、世界のテノキシカムAPI市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（純度≧99%、純度≧99.5%）、用途別セグメント分析（経口、注射）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、TOKYO、INTATRADE、Service Chemical、LGM Pharma、Matrix、Senxuan Pharmaceutical、ShiShun Biotechnology、Dingxintong Pharmaceutical、J&K Scientific、Huibaishi Biotechnology、Meilun Biotechなどが含まれています。テノキシカムAPIのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、テノキシカムAPI市場規模を算出する際に考慮しました。

・テノキシカムAPI市場の概要
- 製品の定義
- テノキシカムAPIの種類別セグメント
- 世界のテノキシカムAPI市場規模：タイプ別分析（純度≧99%、純度≧99.5%）
- テノキシカムAPIの用途別セグメント
- 世界のテノキシカムAPI市場規模：用途別分析（経口、注射）
- 世界のテノキシカムAPI市場規模予測（2018年-2029年）
- テノキシカムAPIの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- テノキシカムAPI市場の競争状況およびトレンド

・テノキシカムAPIの地域別市場規模
- 北米のテノキシカムAPI市場規模（2018年-2029年）
- 米国のテノキシカムAPI市場規模（2018年-2029年）
- ヨーロッパのテノキシカムAPI市場規模（2018年-2029年）
- アジア太平洋のテノキシカムAPI市場規模（2018年-2029年）
- 中国のテノキシカムAPI市場規模（2018年-2029年）
- 日本のテノキシカムAPI市場規模（2018年-2029年）
- 韓国のテノキシカムAPI市場規模（2018年-2029年）
- インドのテノキシカムAPI市場規模（2018年-2029年）
- オーストラリアのテノキシカムAPI市場規模（2018年-2029年）
- 中南米のテノキシカムAPI市場規模（2018年-2029年）
- 中東・アフリカのテノキシカムAPI市場規模（2018年-2029年）

・種類別セグメント：純度≧99%、純度≧99.5%
- 世界のテノキシカムAPIのタイプ別販売量（2018年-2023年）
- 世界のテノキシカムAPIのタイプ別売上（2018年-2023年）
- 世界のテノキシカムAPIのタイプ別価格

・用途別セグメント：経口、注射
- 世界のテノキシカムAPIの用途別販売量（2018年-2023年）
- 世界のテノキシカムAPIの用途別売上（2018年-2023年）
- 世界のテノキシカムAPIの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
TOKYO、INTATRADE、Service Chemical、LGM Pharma、Matrix、Senxuan Pharmaceutical、ShiShun Biotechnology、Dingxintong Pharmaceutical、J&K Scientific、Huibaishi Biotechnology、Meilun Biotech

・産業チェーンと販売チャネルの分析
- テノキシカムAPI産業チェーン分析
- テノキシカムAPIの主要原材料
- テノキシカムAPIの販売チャネル
- テノキシカムAPIのディストリビューター
- テノキシカムAPIの主要顧客

・テノキシカムAPI市場ダイナミクス
- テノキシカムAPIの業界動向
- テノキシカムAPI市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Tenoxicam API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Tenoxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tenoxicam API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Tenoxicam API include TOKYO, INTATRADE, Service Chemical, LGM Pharma, Matrix, Senxuan Pharmaceutical, ShiShun Biotechnology, Dingxintong Pharmaceutical and J&K Scientific, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tenoxicam API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenoxicam API.
The Tenoxicam API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tenoxicam API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenoxicam API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
TOKYO
INTATRADE
Service Chemical
LGM Pharma
Matrix
Senxuan Pharmaceutical
ShiShun Biotechnology
Dingxintong Pharmaceutical
J&K Scientific
Huibaishi Biotechnology
Meilun Biotech
Segment by Type
Purity≥ 99%
Purity≥ 99.5%
Segment by Application
Oral Doses
Injection
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenoxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tenoxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Tenoxicam API Market Overview
1.1 Product Overview and Scope of Tenoxicam API
1.2 Tenoxicam API Segment by Type
1.2.1 Global Tenoxicam API Market Value Comparison by Type (2023-2029)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Tenoxicam API Segment by Application
1.3.1 Global Tenoxicam API Market Value by Application: (2023-2029)
1.3.2 Oral Doses
1.3.3 Injection
1.4 Global Tenoxicam API Market Size Estimates and Forecasts
1.4.1 Global Tenoxicam API Revenue 2018-2029
1.4.2 Global Tenoxicam API Sales 2018-2029
1.4.3 Global Tenoxicam API Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tenoxicam API Market Competition by Manufacturers
2.1 Global Tenoxicam API Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tenoxicam API Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tenoxicam API Average Price by Manufacturers (2018-2023)
2.4 Global Tenoxicam API Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tenoxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenoxicam API, Product Type & Application
2.7 Tenoxicam API Market Competitive Situation and Trends
2.7.1 Tenoxicam API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tenoxicam API Players Market Share by Revenue
2.7.3 Global Tenoxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tenoxicam API Retrospective Market Scenario by Region
3.1 Global Tenoxicam API Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tenoxicam API Global Tenoxicam API Sales by Region: 2018-2029
3.2.1 Global Tenoxicam API Sales by Region: 2018-2023
3.2.2 Global Tenoxicam API Sales by Region: 2024-2029
3.3 Global Tenoxicam API Global Tenoxicam API Revenue by Region: 2018-2029
3.3.1 Global Tenoxicam API Revenue by Region: 2018-2023
3.3.2 Global Tenoxicam API Revenue by Region: 2024-2029
3.4 North America Tenoxicam API Market Facts & Figures by Country
3.4.1 North America Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tenoxicam API Sales by Country (2018-2029)
3.4.3 North America Tenoxicam API Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenoxicam API Market Facts & Figures by Country
3.5.1 Europe Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tenoxicam API Sales by Country (2018-2029)
3.5.3 Europe Tenoxicam API Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tenoxicam API Market Facts & Figures by Country
3.6.1 Asia Pacific Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tenoxicam API Sales by Country (2018-2029)
3.6.3 Asia Pacific Tenoxicam API Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tenoxicam API Market Facts & Figures by Country
3.7.1 Latin America Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tenoxicam API Sales by Country (2018-2029)
3.7.3 Latin America Tenoxicam API Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tenoxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenoxicam API Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tenoxicam API Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tenoxicam API Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenoxicam API Sales by Type (2018-2029)
4.1.1 Global Tenoxicam API Sales by Type (2018-2023)
4.1.2 Global Tenoxicam API Sales by Type (2024-2029)
4.1.3 Global Tenoxicam API Sales Market Share by Type (2018-2029)
4.2 Global Tenoxicam API Revenue by Type (2018-2029)
4.2.1 Global Tenoxicam API Revenue by Type (2018-2023)
4.2.2 Global Tenoxicam API Revenue by Type (2024-2029)
4.2.3 Global Tenoxicam API Revenue Market Share by Type (2018-2029)
4.3 Global Tenoxicam API Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tenoxicam API Sales by Application (2018-2029)
5.1.1 Global Tenoxicam API Sales by Application (2018-2023)
5.1.2 Global Tenoxicam API Sales by Application (2024-2029)
5.1.3 Global Tenoxicam API Sales Market Share by Application (2018-2029)
5.2 Global Tenoxicam API Revenue by Application (2018-2029)
5.2.1 Global Tenoxicam API Revenue by Application (2018-2023)
5.2.2 Global Tenoxicam API Revenue by Application (2024-2029)
5.2.3 Global Tenoxicam API Revenue Market Share by Application (2018-2029)
5.3 Global Tenoxicam API Price by Application (2018-2029)
6 Key Companies Profiled
6.1 TOKYO
6.1.1 TOKYO Corporation Information
6.1.2 TOKYO Description and Business Overview
6.1.3 TOKYO Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.1.4 TOKYO Tenoxicam API Product Portfolio
6.1.5 TOKYO Recent Developments/Updates
6.2 INTATRADE
6.2.1 INTATRADE Corporation Information
6.2.2 INTATRADE Description and Business Overview
6.2.3 INTATRADE Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.2.4 INTATRADE Tenoxicam API Product Portfolio
6.2.5 INTATRADE Recent Developments/Updates
6.3 Service Chemical
6.3.1 Service Chemical Corporation Information
6.3.2 Service Chemical Description and Business Overview
6.3.3 Service Chemical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Service Chemical Tenoxicam API Product Portfolio
6.3.5 Service Chemical Recent Developments/Updates
6.4 LGM Pharma
6.4.1 LGM Pharma Corporation Information
6.4.2 LGM Pharma Description and Business Overview
6.4.3 LGM Pharma Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LGM Pharma Tenoxicam API Product Portfolio
6.4.5 LGM Pharma Recent Developments/Updates
6.5 Matrix
6.5.1 Matrix Corporation Information
6.5.2 Matrix Description and Business Overview
6.5.3 Matrix Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Matrix Tenoxicam API Product Portfolio
6.5.5 Matrix Recent Developments/Updates
6.6 Senxuan Pharmaceutical
6.6.1 Senxuan Pharmaceutical Corporation Information
6.6.2 Senxuan Pharmaceutical Description and Business Overview
6.6.3 Senxuan Pharmaceutical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Senxuan Pharmaceutical Tenoxicam API Product Portfolio
6.6.5 Senxuan Pharmaceutical Recent Developments/Updates
6.7 ShiShun Biotechnology
6.6.1 ShiShun Biotechnology Corporation Information
6.6.2 ShiShun Biotechnology Description and Business Overview
6.6.3 ShiShun Biotechnology Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.4.4 ShiShun Biotechnology Tenoxicam API Product Portfolio
6.7.5 ShiShun Biotechnology Recent Developments/Updates
6.8 Dingxintong Pharmaceutical
6.8.1 Dingxintong Pharmaceutical Corporation Information
6.8.2 Dingxintong Pharmaceutical Description and Business Overview
6.8.3 Dingxintong Pharmaceutical Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dingxintong Pharmaceutical Tenoxicam API Product Portfolio
6.8.5 Dingxintong Pharmaceutical Recent Developments/Updates
6.9 J&K Scientific
6.9.1 J&K Scientific Corporation Information
6.9.2 J&K Scientific Description and Business Overview
6.9.3 J&K Scientific Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.9.4 J&K Scientific Tenoxicam API Product Portfolio
6.9.5 J&K Scientific Recent Developments/Updates
6.10 Huibaishi Biotechnology
6.10.1 Huibaishi Biotechnology Corporation Information
6.10.2 Huibaishi Biotechnology Description and Business Overview
6.10.3 Huibaishi Biotechnology Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Huibaishi Biotechnology Tenoxicam API Product Portfolio
6.10.5 Huibaishi Biotechnology Recent Developments/Updates
6.11 Meilun Biotech
6.11.1 Meilun Biotech Corporation Information
6.11.2 Meilun Biotech Tenoxicam API Description and Business Overview
6.11.3 Meilun Biotech Tenoxicam API Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Meilun Biotech Tenoxicam API Product Portfolio
6.11.5 Meilun Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenoxicam API Industry Chain Analysis
7.2 Tenoxicam API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenoxicam API Production Mode & Process
7.4 Tenoxicam API Sales and Marketing
7.4.1 Tenoxicam API Sales Channels
7.4.2 Tenoxicam API Distributors
7.5 Tenoxicam API Customers
8 Tenoxicam API Market Dynamics
8.1 Tenoxicam API Industry Trends
8.2 Tenoxicam API Market Drivers
8.3 Tenoxicam API Market Challenges
8.4 Tenoxicam API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Tenoxicam API Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Tenoxicam API Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Tenoxicam API Market Competitive Situation by Manufacturers in 2022
Table 4. Global Tenoxicam API Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Tenoxicam API Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Tenoxicam API Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Tenoxicam API Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Tenoxicam API Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Tenoxicam API, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Tenoxicam API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tenoxicam API, Product Type & Application
Table 12. Global Key Manufacturers of Tenoxicam API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenoxicam API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenoxicam API as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenoxicam API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Tenoxicam API Sales by Region (2018-2023) & (K Units)
Table 18. Global Tenoxicam API Sales Market Share by Region (2018-2023)
Table 19. Global Tenoxicam API Sales by Region (2024-2029) & (K Units)
Table 20. Global Tenoxicam API Sales Market Share by Region (2024-2029)
Table 21. Global Tenoxicam API Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Tenoxicam API Revenue Market Share by Region (2018-2023)
Table 23. Global Tenoxicam API Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Tenoxicam API Revenue Market Share by Region (2024-2029)
Table 25. North America Tenoxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Tenoxicam API Sales by Country (2018-2023) & (K Units)
Table 27. North America Tenoxicam API Sales by Country (2024-2029) & (K Units)
Table 28. North America Tenoxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Tenoxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Tenoxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Tenoxicam API Sales by Country (2018-2023) & (K Units)
Table 32. Europe Tenoxicam API Sales by Country (2024-2029) & (K Units)
Table 33. Europe Tenoxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Tenoxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Tenoxicam API Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Tenoxicam API Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Tenoxicam API Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Tenoxicam API Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Tenoxicam API Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Tenoxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Tenoxicam API Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Tenoxicam API Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Tenoxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Tenoxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Tenoxicam API Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Tenoxicam API Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Tenoxicam API Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Tenoxicam API Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Tenoxicam API Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Tenoxicam API Sales (K Units) by Type (2018-2023)
Table 51. Global Tenoxicam API Sales (K Units) by Type (2024-2029)
Table 52. Global Tenoxicam API Sales Market Share by Type (2018-2023)
Table 53. Global Tenoxicam API Sales Market Share by Type (2024-2029)
Table 54. Global Tenoxicam API Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Tenoxicam API Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Tenoxicam API Revenue Market Share by Type (2018-2023)
Table 57. Global Tenoxicam API Revenue Market Share by Type (2024-2029)
Table 58. Global Tenoxicam API Price (US$/Unit) by Type (2018-2023)
Table 59. Global Tenoxicam API Price (US$/Unit) by Type (2024-2029)
Table 60. Global Tenoxicam API Sales (K Units) by Application (2018-2023)
Table 61. Global Tenoxicam API Sales (K Units) by Application (2024-2029)
Table 62. Global Tenoxicam API Sales Market Share by Application (2018-2023)
Table 63. Global Tenoxicam API Sales Market Share by Application (2024-2029)
Table 64. Global Tenoxicam API Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Tenoxicam API Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Tenoxicam API Revenue Market Share by Application (2018-2023)
Table 67. Global Tenoxicam API Revenue Market Share by Application (2024-2029)
Table 68. Global Tenoxicam API Price (US$/Unit) by Application (2018-2023)
Table 69. Global Tenoxicam API Price (US$/Unit) by Application (2024-2029)
Table 70. TOKYO Corporation Information
Table 71. TOKYO Description and Business Overview
Table 72. TOKYO Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. TOKYO Tenoxicam API Product
Table 74. TOKYO Recent Developments/Updates
Table 75. INTATRADE Corporation Information
Table 76. INTATRADE Description and Business Overview
Table 77. INTATRADE Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. INTATRADE Tenoxicam API Product
Table 79. INTATRADE Recent Developments/Updates
Table 80. Service Chemical Corporation Information
Table 81. Service Chemical Description and Business Overview
Table 82. Service Chemical Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Service Chemical Tenoxicam API Product
Table 84. Service Chemical Recent Developments/Updates
Table 85. LGM Pharma Corporation Information
Table 86. LGM Pharma Description and Business Overview
Table 87. LGM Pharma Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. LGM Pharma Tenoxicam API Product
Table 89. LGM Pharma Recent Developments/Updates
Table 90. Matrix Corporation Information
Table 91. Matrix Description and Business Overview
Table 92. Matrix Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Matrix Tenoxicam API Product
Table 94. Matrix Recent Developments/Updates
Table 95. Senxuan Pharmaceutical Corporation Information
Table 96. Senxuan Pharmaceutical Description and Business Overview
Table 97. Senxuan Pharmaceutical Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Senxuan Pharmaceutical Tenoxicam API Product
Table 99. Senxuan Pharmaceutical Recent Developments/Updates
Table 100. ShiShun Biotechnology Corporation Information
Table 101. ShiShun Biotechnology Description and Business Overview
Table 102. ShiShun Biotechnology Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. ShiShun Biotechnology Tenoxicam API Product
Table 104. ShiShun Biotechnology Recent Developments/Updates
Table 105. Dingxintong Pharmaceutical Corporation Information
Table 106. Dingxintong Pharmaceutical Description and Business Overview
Table 107. Dingxintong Pharmaceutical Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Dingxintong Pharmaceutical Tenoxicam API Product
Table 109. Dingxintong Pharmaceutical Recent Developments/Updates
Table 110. J&K Scientific Corporation Information
Table 111. J&K Scientific Description and Business Overview
Table 112. J&K Scientific Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. J&K Scientific Tenoxicam API Product
Table 114. J&K Scientific Recent Developments/Updates
Table 115. Huibaishi Biotechnology Corporation Information
Table 116. Huibaishi Biotechnology Description and Business Overview
Table 117. Huibaishi Biotechnology Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Huibaishi Biotechnology Tenoxicam API Product
Table 119. Huibaishi Biotechnology Recent Developments/Updates
Table 120. Meilun Biotech Corporation Information
Table 121. Meilun Biotech Description and Business Overview
Table 122. Meilun Biotech Tenoxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Meilun Biotech Tenoxicam API Product
Table 124. Meilun Biotech Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tenoxicam API Distributors List
Table 128. Tenoxicam API Customers List
Table 129. Tenoxicam API Market Trends
Table 130. Tenoxicam API Market Drivers
Table 131. Tenoxicam API Market Challenges
Table 132. Tenoxicam API Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tenoxicam API
Figure 2. Global Tenoxicam API Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Tenoxicam API Market Share by Type in 2022 & 2029
Figure 4. Purity≥ 99% Product Picture
Figure 5. Purity≥ 99.5% Product Picture
Figure 6. Global Tenoxicam API Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Tenoxicam API Market Share by Application in 2022 & 2029
Figure 8. Oral Doses
Figure 9. Injection
Figure 10. Global Tenoxicam API Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Tenoxicam API Market Size (2018-2029) & (US$ Million)
Figure 12. Global Tenoxicam API Sales (2018-2029) & (K Units)
Figure 13. Global Tenoxicam API Average Price (US$/Unit) & (2018-2029)
Figure 14. Tenoxicam API Report Years Considered
Figure 15. Tenoxicam API Sales Share by Manufacturers in 2022
Figure 16. Global Tenoxicam API Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Tenoxicam API Players: Market Share by Revenue in 2022
Figure 18. Tenoxicam API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Tenoxicam API Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Tenoxicam API Sales Market Share by Country (2018-2029)
Figure 21. North America Tenoxicam API Revenue Market Share by Country (2018-2029)
Figure 22. United States Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Tenoxicam API Sales Market Share by Country (2018-2029)
Figure 25. Europe Tenoxicam API Revenue Market Share by Country (2018-2029)
Figure 26. Germany Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Tenoxicam API Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Tenoxicam API Revenue Market Share by Region (2018-2029)
Figure 33. China Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Tenoxicam API Sales Market Share by Country (2018-2029)
Figure 43. Latin America Tenoxicam API Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Tenoxicam API Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Tenoxicam API Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Tenoxicam API Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Tenoxicam API by Type (2018-2029)
Figure 54. Global Revenue Market Share of Tenoxicam API by Type (2018-2029)
Figure 55. Global Tenoxicam API Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Tenoxicam API by Application (2018-2029)
Figure 57. Global Revenue Market Share of Tenoxicam API by Application (2018-2029)
Figure 58. Global Tenoxicam API Price (US$/Unit) by Application (2018-2029)
Figure 59. Tenoxicam API Value Chain
Figure 60. Tenoxicam API Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • サル痘ウイルス核酸検出キット（蛍光PCR）の世界市場2023年：ダブルPCR検出、トリプルPCRアッセイ
  • 組換えヒトインターフェロンα2b注射の世界市場2023年：短時間作用型、長時間作用型
  • 顔＆唇用フィラーの世界市場2023年：ヒアルロン酸、コラーゲン、CaHA、その他
  • 医療美容材料の世界市場2023年：ヒアルロン酸、コラーゲン、水素カルシウム、その他皮膚フィラー、ボツリヌストキシン、乳房インプラント、その他
  • モキソニジン塩酸塩の世界市場2023年：錠剤、カプセル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8904 )"テノキシカムAPIの世界市場2023年：純度≧99%、純度≧99.5%" (英文：Global Tenoxicam API Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。